Active — Not RecruitingNot Applicable

Assessment of Biomarkers in Children to Help Parents Quit Tobacco

United States865 participantsStarted 2023-01-20

Plain-language summary

This randomized controlled trial will test whether adding biomarker measurement and informed outreach for tobacco smoke exposure as part of routine practice increases identification and improves treatment, effectiveness, and sustainability of a parental tobacco control intervention that will be integrated into pediatric practice.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Child 12 years old or younger presenting for a visit.
✓. Child scheduled for or has had a clinically indicated blood draw at that visit
✓. Parent/legal guardian of the child.
✓. Parent/legal guardian is a current smoker (past 7 days).

Exclusion criteria

✕. Parent/legal guardian is non-English speaking.
✕. Parent/legal guardian is less than 18 years of age.

What they're measuring

Parental quit rate

Timeframe: 12 months

Trial details

NCT IDNCT04832659

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05-15

View on ClinicalTrials.gov More Tobacco Dependence trials